Anteris grants CFO 90K stock options at $8.35

Anteris Technologies Global Corp.’s CFO received a multi-year vesting grant of 90,274 stock options at a $8.35 exercise price.

Available on EDGAR 09/16/2026 - 02:18 PM EDT Accepted by SEC EDGAR 09/16/2026 - 02:18 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Anteris Technologies Global Corp. (AVR) reported that its Chief Financial Officer, Moen Brent, received a grant of 90,274 employee stock options on September 11, 2026. The options have an exercise price of $8.35 per share, expire on September 11, 2036, and vest in approximately equal installments on September 11, 2027, 2028, and 2029, subject to continued service.

Insider Trade Summary

Grant/Award: 90,274 shares

Grant/Award 1 txn

Insider Moen Brent

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy) F1	90,274	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 90,274 contracts (Direct)

Holdings Before and After: Employee Stock Option (right to buy), 0 to 90,274 contracts (Direct)

Footnotes (1)

1. F1. On September 11, 2026, the Reporting Person was granted 90,274 stock options, which vest in approximately equal installments on September 11, 2027, September 11, 2028 and September 11, 2029, subject to the Reporting Person's continued service through each vesting date.

Key Figures

Options granted: 90,274 options Exercise price: $8.35 per share Expiration date: September 11, 2036 +2 more

5 metrics

Options granted 90,274 options Employee stock options granted to CFO on September 11, 2026

Exercise price $8.35 per share Exercise price for the 90,274 options granted

Expiration date September 11, 2036 Expiration of the employee stock options granted to the CFO

Underlying shares 90,274 shares Common shares underlying the employee stock options

Vesting dates September 11, 2027; September 11, 2028; September 11, 2029 Approximately equal installments, subject to continued service

Key Terms

Employee Stock Option, exercise price, vesting, expiration date

4 terms

Employee Stock Option financial

"Employee Stock Option (right to buy)"

An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.

exercise price financial

"have an exercise price of $8.35 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"which vest in approximately equal installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

expiration date financial

"expire on September 11, 2036"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Anteris Technologies Global Corp. (AVR) report for its CFO?

The company reported that CFO Moen Brent was granted 90,274 employee stock options on September 11, 2026, as equity compensation. These options give the right to buy Anteris Technologies Global Corp. common stock, subject to an exercise price and vesting schedule.

What is the exercise price of the new stock options granted by AVR to its CFO?

The stock options granted to the CFO have an exercise price of $8.35 per share. This is the price at which the holder may purchase Anteris Technologies Global Corp. common stock once the options have vested and are exercised.

How many Anteris Technologies Global Corp. (AVR) options does the CFO hold after this grant?

After this reported grant, the CFO holds 90,274 employee stock options directly. These options are all tied to Anteris Technologies Global Corp. common stock and are subject to the stated vesting and expiration terms.

What is the vesting schedule of the AVR stock options granted to the CFO?

The 90,274 options granted to the CFO vest in approximately equal installments on September 11, 2027, September 11, 2028, and September 11, 2029, and each installment is subject to the CFO’s continued service through the applicable vesting date.

When do the newly granted AVR options to the CFO expire?

The options granted to the CFO on September 11, 2026 carry an expiration date of September 11, 2036. After that date, any unexercised options will no longer be exercisable for Anteris Technologies Global Corp. common stock.

Were the AVR CFO’s option grants made under a Rule 10b5-1 trading plan?

No. The filing indicates that no Rule 10b5-1 trading plan is reported in connection with this option grant to the CFO. It is disclosed as an equity award, not as a transaction executed under a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moen Brent

(Last) (First) (Middle)

TOOWONG TOWER, LEVEL 3

SUITE 302, 9 SHERWOOD ROAD

(Street)

TOOWONG QLD 4066

(City) (State) (Zip)

AUSTRALIA

(Country)

2. Issuer Name and Ticker or Trading Symbol
Anteris Technologies Global Corp. [ AVR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol
[(AVR)]

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$8.35	09/11/2026		A		90,274		(1)	09/11/2036	Common Stock	90,274	$0	90,274	D

Explanation of Responses:

1. On September 11, 2026, the Reporting Person was granted 90,274 stock options, which vest in approximately equal installments on September 11, 2027, September 11, 2028 and September 11, 2029, subject to the Reporting Person's continued service through each vesting date.

	/s/ Brent Moen	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)